10562: Iridex EndoProbe Intraocular Laser Delivery Handpiece 20G, Standard Straight

Sign in to add this product to your favorites!
| Price: | $5.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 19 eaches |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 5 hours 50 minutes and choose overnight shipping at checkout. |
Additional Details
IRIDEX 10562 20G Standard Straight EndoProbe
The IRIDEX 10562 EndoProbe is a 20-gauge standard straight intraocular laser delivery handpiece for retinal photocoagulation during vitreoretinal surgery. Its straight, tapered configuration provides direct access to retinal treatment sites through a sclerotomy.
Product Code: 10562
- Manufacturer: IRIDEX
- Product Name: Standard Straight EndoProbe
- Device Type: Intraocular laser delivery handpiece
- Gauge: 20G
- Tip Configuration: Straight
- Clinical Application: Retinal photocoagulation and intraocular endophotocoagulation
- Anatomical Application: Posterior segment and retina
- Specialty: Ophthalmology
- Compatibility: IRIDEX laser systems specified for EndoProbe handpieces
Features
- Straight configuration provides direct access to the treatment site
- Designed for insertion and extraction through the sclerotomy
- Tapered tip supports insertion and visibility
- Fiber-optic construction delivers laser energy intraocularly
Sterilization
- Device Packaged as Sterile: Yes
- Requires Sterilization Prior to Use: No
- Single-Use, Disposable
Manufacturer
Iridex Corporation is a medical device company specializing in laser-based ophthalmic treatments for glaucoma and retinal diseases. Their proprietary MicroPulse laser technology delivers precise, tissue-sparing energy for glaucoma therapies, such as MicroPulse transscleral laser therapy (TLT), and retinal applications, including diabetic macular edema (DME) and age-related macular degeneration (AMD). Iridex also offers conventional continuous-wave laser systems for retinal photocoagulation, as well as an extensive line of laser probes, delivery devices, and accessories. The company’s solutions focus on minimally invasive, repeatable treatments aimed at preserving vision and improving quality of life for patients with chronic eye conditions.
IN-DATE